Mondelez (MDLZ) reported $8.98 billion in revenue for the quarter ended June 2025, representing a year-over- year increase of 7.7%. EPS of $0.73 for the same period compares to $0.86 a year ago. Here is how Mondelez performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: View all Key Company Metrics for Mondelez here>>> While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare t ...

For the quarter ended June 2025, Varonis Systems (VRNS) reported revenue of $152.16 million, up 16.7% over the same period last year. EPS came in at $0.03, compared to $0.05 in the year-ago quarter. View all Key Company Metrics for Varonis here>>> Shares of Varonis have returned +7.2% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Annual Recurring Revenue ...

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Electronic Arts performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: For the quarter ended June 2025, Electronic Arts (EA) reported revenue of $1.3 billion, up 2.9% over the same period last year. EPS came in at $0.25, compared to $ ...

NMI Holdings (NMIH) reported $173.78 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 7.2%. EPS of $1.22 for the same period compares to $1.20 a year ago. Shares of NMI Holdings have returned -10.4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. The reported revenue represents a surprise of +1.87% over the Zack ...

Core Insights - Merck (MRK) reported Q2 2025 adjusted EPS of $2.13, exceeding estimates, but a 7% decline year-over-year on a reported basis due to a $200 million upfront payment for a license agreement with Hengrui Pharma [2][9][17] - Revenues decreased 2% year-over-year to $15.81 billion, aligning with consensus estimates [3][9] Sales Performance of Oncology Drugs - Keytruda sales reached $7.96 billion, a 9% increase, driven by strong uptake in various cancer indications, surpassing estimates [4][9] - Alliance revenues from Lynparza and Lenvima contributed positively, with Lynparza sales up 15% to $370 million and Lenvima revenues totaling $265 million, up 5% [5] Sales Performance of Other Key Products - HPV vaccine sales (Gardasil and Gardasil 9) fell 55% to $1.13 billion due to reduced demand in China, missing estimates [7] - Sales of other vaccines showed mixed results, with Vaxneuvance increasing 20% to $229 million, while Rotateq and Pneumovax 23 saw significant declines [8][10] Animal Health Segment - The Animal Health segment generated $1.65 billion in revenues, an 11% increase year-over-year, driven by higher demand and the inclusion of Elanco aqua business sales [12] Cost and Margin Discussion - Adjusted gross margin improved to 82.2%, up 130 basis points year-over-year, attributed to a favorable product mix [13] - Adjusted R&D spending rose 15% to $3.99 billion, influenced by the upfront payment to Hengrui Pharma and increased compensation costs [14] 2025 Guidance - Merck narrowed its 2025 revenue guidance to $64.3-$65.3 billion, reflecting a less negative currency impact [15] - Adjusted EPS guidance is now between $8.87 and $8.97, accounting for a revised negative impact from foreign exchange [16] Acquisition Plans - Merck announced plans to acquire Verona Pharma for approximately $10 billion, expected to close in Q4 2025, which will enhance its portfolio in chronic obstructive pulmonary disease [19]

Core Insights - Lear Corp. (LEA) reported Q2 2025 adjusted earnings per share of $3.47, exceeding the Zacks Consensus Estimate of $3.23, driven by strong performance in the Seating and E-Systems segments, although down from $3.60 in the same quarter last year [1][9] - Total revenues for the quarter were flat year-over-year at $6.03 billion, surpassing the Zacks Consensus Estimate of $5.89 billion [1][9] Segmental Performance - The Seating segment generated sales of $4.47 billion, slightly up from $4.45 billion year-over-year, and exceeded the Zacks Consensus Estimate of $4.37 billion. Adjusted segment earnings were $298.9 million, down from $302.1 million year-over-year but above the estimate of $276 million, with adjusted margins at 6.7% [2] - The E-Systems segment reported sales of $1.56 billion, a 0.6% decline year-over-year, but still above the Zacks Consensus Estimate of $1.52 billion. Adjusted earnings were $75.8 million, down from $82.2 million year-over-year, yet surpassing the estimate of $67 million, with adjusted margins at 4.9% [3] Performance by Region - North America sales decreased by 1.3% year-over-year to $2.52 billion, exceeding the Zacks Consensus Estimate of $2.44 billion [4] - Europe and Africa region sales fell by 0.39% year-over-year to $2.16 billion, beating the Zacks Consensus Estimate of $2.13 billion [4] - Asia region sales increased by 6.5% year-over-year to $1.14 billion, surpassing the Zacks Consensus Estimate of $1.13 billion [4] Financial Position & Other Tidbits - As of June 28, 2025, the company had $888 million in cash and cash equivalents, down from $1.05 billion at the end of 2024. Long-term debt increased to $2.76 billion [6] - Net cash used in operating activities for the quarter was $296.2 million, with a free cash flow (FCF) of $170.8 million [6] - During the quarter, Lear repurchased 271,117 shares for a total of $25 million, with nearly $1 billion remaining in share repurchase authorization [7] 2025 Guidance - Lear projects full-year net sales between $22.47 billion and $23.07 billion, with core operating earnings expected in the range of $955 million to $1,095 million. Operating cash flow is anticipated to be between $1.01 billion and $1.11 billion, with FCF projected between $420 million and $520 million and capital spending estimated at $590 million [9][10]

Core Insights - Rambus Inc. reported second-quarter 2025 non-GAAP earnings of 60 cents per share, missing the Zacks Consensus Estimate by one cent, but showing a year-over-year increase of 30.4% [1][9] - Revenues for the second quarter reached $172.2 million, a 30.4% increase year-over-year, surpassing the Zacks Consensus Estimate by 3.1%, driven by strong demand across all segments [1][9] Revenue Breakdown - Product revenues amounted to $81.3 million, representing 47.2% of total revenues, and increased by 43.4% year-over-year, primarily due to growth in memory products, particularly DDR5 [2] - Royalties generated $68.6 million, accounting for 39.8% of total revenues, up 21.6% year-over-year, driven by increased recurring revenues from licensing Rambus patents by semiconductor companies [2] - Revenues from Contract and Other reached $22.3 million, making up 12.9% of total revenues, and increased by 16.8% year-over-year, mainly due to growth in Silicon IP [3] Profitability Metrics - Rambus reported a gross profit of $137.4 million for the second quarter, up from $105.3 million in the same quarter last year, with a gross margin of 79.8%, an improvement of 10 basis points year-over-year [3] - Non-GAAP operating expenses were $60.4 million, while non-GAAP operating income rose 43.4% year-over-year to $79 million, resulting in an operating margin of 45.9% [4] Balance Sheet and Cash Flow - As of June 30, 2025, Rambus had cash and marketable securities totaling $594.8 million, up from $514.4 million at the end of the previous quarter, with no debt on the balance sheet [5] - The company generated an operating cash flow of $94.4 million in the second quarter and reported free cash flow of $84 million [5] Guidance for Q3 - Rambus provided guidance for Q3 2025, projecting non-GAAP product revenues between $87 million and $93 million, Contract & Other revenues in the range of $22 million to $28 million, and Licensing Billings between $58 million and $64 million [6][7] - The Zacks Consensus Estimates for Rambus' top line is $172 million, indicating a year-over-year growth of 17.2% [6] - Expected non-GAAP earnings per share for Q3 are projected to be between 58 cents and 66 cents, with the consensus estimate at 61 cents per share, reflecting a year-over-year growth of 22% [7]

Market Overview - Pre-market futures are up due to various earnings reports, economic data, and a significant railway merger [1] - The Dow is slightly down by 12 points, while the S&P 500 is up by 11 points, and the Nasdaq is up by 88 points [1] Railway Merger - Union Pacific (UNP) is set to acquire Norfolk Southern (NSC) for $72 billion, or $320 per share, creating the first trans-continental railroad in the U.S. [2] - The merger requires approval from the Surface Transportation Board, and the current administration may favor the deal despite monopolistic concerns [3] Trade Balance - The Advanced U.S. Trade Balance in Goods for June shows a pullback to -$86 billion, better than expected, driven by a 4.2% decline in imports [4] - This indicates a slowdown in trade due to higher tariff expectations, contrasting with the record-low trade balance of -$162 billion in March 2025 [4] Q2 Earnings Highlights - Boeing (BA) reported a Q2 loss of $1.24 per share, improving by 30 cents over consensus, with revenues of $22.75 billion exceeding estimates by 4.1% [5] - UnitedHealth (UNH) missed earnings expectations with $4.08 per share versus $4.84 expected, while revenues of $111.6 billion slightly beat estimates [6] - Royal Caribbean (RCL) reported earnings of $4.38 per share, surpassing consensus by 6.8%, despite revenues of $4.54 billion missing projections [7] - Spotify (SPOT) reported a loss of $0.48 per share, significantly missing the $2.13 consensus estimate, with revenues of $4.76 billion also falling short [8]

Core Insights - Paypal reported revenue of $8.29 billion for the quarter ended June 2025, reflecting a 5.1% increase year-over-year and a surprise of +2.26% over the Zacks Consensus Estimate of $8.1 billion [1] - The earnings per share (EPS) was $1.40, up from $1.19 in the same quarter last year, surpassing the consensus EPS estimate of $1.30 by +7.69% [1] Financial Performance Metrics - Transaction margin was reported at 46.4%, slightly below the six-analyst average estimate of 46.7% [4] - Transaction take rate remained consistent at 1.7%, matching the six-analyst average estimate [4] - Total Payment Volume (TPV) reached $443.55 billion, exceeding the average estimate of $434.45 billion based on five analysts [4] - Transaction expense rate was 0.9%, aligning with the average estimate from four analysts [4] - Total take rate was reported at 1.9%, consistent with the four-analyst average estimate [4] - Active accounts stood at 438, matching the estimate from three analysts [4] - Transaction and Credit loss rate was 0.1%, in line with the three-analyst average estimate [4] - The number of payment transactions was 6,226, below the average estimate of 6,722 based on two analysts [4] - Revenues from other value-added services were $847 million, surpassing the eight-analyst average estimate of $766.91 million, representing a year-over-year change of +15.7% [4] - Transaction revenues amounted to $7.44 billion, exceeding the eight-analyst average estimate of $7.31 billion, with a year-over-year change of +4% [4] Stock Performance - Shares of Paypal have returned +5.3% over the past month, outperforming the Zacks S&P 500 composite's +3.6% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Ares Capital (ARCC) reported $745 million in revenue for the quarter ended June 2025, representing a year- over-year decline of 1.3%. EPS of $0.50 for the same period compares to $0.61 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $746.71 million, representing a surprise of -0.23%. The company delivered an EPS surprise of -1.96%, with the consensus EPS estimate being $0.51. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...